NDA 20627, held by Wyeth Pharms Inc. Levonorgestrel.
As of Nov 14, 2026, NDA 20627 (Levonorgestrel), held by Wyeth Pharms Inc, was first approved by FDA on Aug 15, 1996, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Aug 15, 1996 | Original applicationNew dosage form · Standard review | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Levonorgestrel75MG/IMPLANT · implant;implantation | Levonorgestrel | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
